These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9696366)

  • 41. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases.
    Chamberlain MC; Kormanik PA; Barba D
    J Neurosurg; 1997 Nov; 87(5):694-9. PubMed ID: 9347977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current treatment of leptomeningeal metastases: systemic chemotherapy, intrathecal chemotherapy and symptom management.
    Berg SL; Chamberlain MC
    Cancer Treat Res; 2005; 125():121-46. PubMed ID: 16211887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe.
    Le Rhun E; Rudà R; Devos P; Hoang-Xuan K; Brandsma D; Pérez Segura P; Soffietti R; Weller M
    J Neurooncol; 2017 Jun; 133(2):419-427. PubMed ID: 28455788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Revisiting intrathecal thiotepa: Efficacy and safety in secondary CNS malignancies.
    Jamison T; Haque E; Muhsen IN; Samarkandi H; Fakih RE; Aljurf M
    Med Oncol; 2024 Jun; 41(7):177. PubMed ID: 38884819
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients.
    Wasserstrom WR; Glass JP; Posner JB
    Cancer; 1982 Feb; 49(4):759-72. PubMed ID: 6895713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radioisotope CSF flow studies in leptomeningeal metastases.
    Chamberlain MC
    J Neurooncol; 1998; 38(2-3):135-40. PubMed ID: 9696363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leptomeningeal metastasis.
    Taillibert S; Chamberlain MC
    Handb Clin Neurol; 2018; 149():169-204. PubMed ID: 29307353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
    Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
    Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Leptomeningeal metastases from a primary central nervous system melanoma: a case report and literature review.
    Pan Z; Yang G; Wang Y; Yuan T; Gao Y; Dong L
    World J Surg Oncol; 2014 Aug; 12():265. PubMed ID: 25142885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases.
    Mason WP; Yeh SD; DeAngelis LM
    Neurology; 1998 Feb; 50(2):438-44. PubMed ID: 9484369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
    Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
    Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resolution of extensive leptomeningeal metastasis and clinical spinal cord compression from breast cancer using weekly docetaxel chemotherapy.
    Wilson B; Sapp C; Abdeen G; Kamona A; Massarweh S
    Breast Cancer Res Treat; 2012 Jan; 131(1):343-6. PubMed ID: 22037782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment modalities for leptomeningeal metastases.
    Shapiro WR; Johanson CE; Boogerd W
    Semin Oncol; 2009 Aug; 36(4 Suppl 2):S46-54. PubMed ID: 19660683
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience.
    Jo JC; Kang MJ; Kim JE; Ahn JH; Jung KH; Gong G; Kim HH; Ahn SD; Kim SS; Son BH; Ahn SH; Kim SB
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):201-7. PubMed ID: 23670641
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leptomeningeal metastases: analysis of 31 patients with sustained off-therapy response following combined-modality therapy.
    Siegal T; Lossos A; Pfeffer MR
    Neurology; 1994 Aug; 44(8):1463-9. PubMed ID: 8058150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Guideline 'Leptomeningeal metastases of solid tumours'].
    Boogerd W; du Bois WF; Teepen JL; Rosenbrand CJ
    Ned Tijdschr Geneeskd; 2007 Jan; 151(2):123-8. PubMed ID: 17315489
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intra-CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases.
    Jaeckle KA; Dixon JG; Anderson SK; Moreno-Aspitia A; Colon-Otero G; Hebenstreit K; Patel TA; Reddy SL; Perez EA
    Cancer Med; 2020 Nov; 9(21):7935-7942. PubMed ID: 32885617
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leptomeningeal metastases from solid malignancy: a review.
    Taillibert S; Laigle-Donadey F; Chodkiewicz C; Sanson M; Hoang-Xuan K; Delattre JY
    J Neurooncol; 2005 Oct; 75(1):85-99. PubMed ID: 16215819
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Breast cancer leptomeningeal metastasis--the role of multimodality treatment.
    Rudnicka H; Niwińska A; Murawska M
    J Neurooncol; 2007 Aug; 84(1):57-62. PubMed ID: 17310266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic significance of 111indium-DTPA CSF flow studies in leptomeningeal metastases.
    Chamberlain MC; Kormanik PA
    Neurology; 1996 Jun; 46(6):1674-7. PubMed ID: 8649568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.